- QIAGEN (NYSE:QGEN) commences the U.S. commercialization of its portable digital QIAreach SARS-CoV-2 Antigen Test that, it says, can generate results in 2-15 minutes and can process over 30 samples per hour.
- It expects to file a CE Mark application as early as year-end.
- https://seekingalpha.com/news/3635147-qiagen-launches-portable-rapid-sars-covminus-2-antigen-test
Wednesday, November 11, 2020
Qiagen launches portable rapid SARS-CoV-2 antigen test
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.